Related Experiment Video
Updated: Jun 2, 2026

Development, Characterization, and Evaluation of CAGE-based Ionic Liquid Systems for Transdermal Delivery
Published on: September 26, 2025
Ionic liquids as active pharmaceutical ingredients
Ricardo Ferraz1, Luís C Branco, Cristina Prudêncio
1Ciências Químicas e das Biomoléculas, Escola Superior de Tecnologia da Saúde do Porto do Instituto Politécnico do Porto, Rua Valente Perfeito 322, 4400-330 Vila Nova de Gaia, Portugal. ricardoferraz@eu.ipp.pt
Third-generation ionic liquids (ILs) incorporate active pharmaceutical ingredients (APIs) for biological activity. This research highlights advancements in API-ILs, addressing challenges and proposing new medical treatments and delivery methods.
Area of Science:
- Chemistry
- Materials Science
- Pharmaceutical Science
Background:
- Ionic liquids (ILs) are ionic compounds with melting points below 100 °C, exhibiting diverse physical and chemical properties.
- ILs have evolved through three generations, with each offering enhanced functionalities and applications.
- The third generation of ILs integrates active pharmaceutical ingredients (APIs) to create compounds with inherent biological activity.
Purpose of the Study:
- To review recent developments in third-generation ionic liquids (API-ILs).
- To focus on overcoming challenges associated with using APIs in ionic liquid formulations.
- To present innovative solutions for novel medical treatments and drug delivery systems using API-ILs.
Main Methods:
- Literature review of recent advancements in third-generation ionic liquids.
- Analysis of strategies for overcoming hurdles in API-IL development.
- Exploration of novel applications in medical treatment and drug delivery.
Main Results:
- Third-generation ILs are emerging as a significant area of research, particularly for pharmaceutical applications.
- Progress has been made in addressing challenges related to the stability, efficacy, and delivery of API-ILs.
- New therapeutic and delivery approaches utilizing API-ILs are being developed.
Conclusions:
- Third-generation ionic liquids represent a promising frontier in medicinal chemistry and drug delivery.
- Continued research into API-ILs holds potential for significant advancements in healthcare.
- Overcoming current challenges will unlock the full therapeutic potential of these novel compounds.
Related Concept Videos
Pharmaceutical Equivalents
Local Anesthetics: Chemistry and Structure-Activity Relationship
Ion Exchange
Surface Active Agents
Factors Influencing Drug Absorption: Pharmaceutical Parameters
Ion-Exchange Chromatography

